The Rise of Companion Diagnostics

Companion Diagnostics can identify patients who are most likely to benefit from a particular therapeutic, highlight those at increased risk for serious side effects as a result of treatment with a particular therapeutic, and monitor treatment response to a particular therapeutic.

Since the approval of Herceptin® in 1998, companion diagnostics have played a vital role in the safe and effective use of a corresponding drug.

Learn more about companion diagnostics including:

• the growth in the market
• the technologies used
• the challenges and benefits
• the future